(a) If an applicant of a patent application fails to reply within the time period provided under § 1.134 and § 1.136, the application will become abandoned unless an Office action indicates otherwise.
(b) Prosecution of an application to save it from abandonment pursuant to paragraph (a) of this section must include such complete and proper reply as the condition of the application may require. The admission of, or refusal to admit, any amendment after final rejection or any amendment not responsive to the last action, or any related proceedings, will not operate to save the application from abandonment.
(c) When reply by the applicant is a bona fide attempt to advance the application to final action, and is substantially a complete reply to the non-final Office action, but consideration of some matter or compliance with some requirement has been inadvertently omitted, applicant may be given a new time period for reply under § 1.134 to supply the omission.
[62 FR 53194, Oct. 10, 1997]
Notes of Decisions
Cited in
13
cases (
2 in the last 5 years), 1970–2021 · leading case:
Pfizer, Inc. v. Lee, 811 F.3d 466 (Fed. Cir. 2016).
Pfizer, Inc. v. Lee, 811 F.3d 466 (Fed. Cir. 2016).
· cites it 2× “Instead of the highly irregular action conjured by the panel majority—an action of uncertain propriety and unlikely responsiveness, an action that could well have backfired, see 37 C.F.R. 1.135(b) (an incomplete reply leads to abandonment of the application); MPEP § 711.”
Margolis v. Banner, 599 F.2d 435 (C.C.P.A. 1979).
“He reasoned that since petitioners’ response to the second office action 9 failed to specify who was the prior inventor, as requested by the examiner, and since that failure was not inadvertent, the application became abandoned for failure to prosecute by virtue of 35 U.”
Exelixis, Inc. v. Kappos, 906 F. Supp. 2d 474 (E.D. Va. 2012).
“See 37 C.F.R. § 1.135 . An RCE, which may consist of (but is not limited to) “an information disclosure statement, an amendment to the written description, claims, or drawings, new arguments, or new evidence in support of patentability,” functions to continue the examination of…”
Chinsammy v. United States, 95 Fed. Cl. 21 (Fed. Cl. 2010).
“”); 37 C.F.R. § 1.135 (a) (2010) (“Abandonment for failure to reply within time period.”
Star Fruits S.N.C. v. United States, 280 F. Supp. 2d 512 (E.D. Va. 2003).
· cites it 3× “§ 133 ; 37 C.F.R. § 1.135 . Failure to file a timely reply to an Office Action constitutes abandonment.”
New South Indus., Inc. v. Apache Grounding Corp., 666 F. Supp. 1067 (M.D. Tenn. 1987).
· cites it 2× “At the time of the PTO events at issue, 37 C.F.R. § 1.135 provided: (c) When action by the applicant is a bona fide attempt to advance the case to final action, and is substantially a complete response to the examiner’s action, but consideration of some matter or compliance with…”
Enzo Therapeutics, Inc. v. Yeda Rsch. & Dev. Co., 477 F. Supp. 2d 699 (E.D. Va. 2007).
“§ 133 (emphasis added); see also 37 C.F.R. § 1.135 (2006) (“If an applicant of a patent application fails to reply within the time period provided under § 1.”
— 37 C.F.R. § 1.135(b) — 1 case
Pfizer, Inc. v. Lee, 811 F.3d 466 (Fed. Cir. 2016).
“Instead of the highly irregular action conjured by the panel majority—an action of uncertain propriety and unlikely responsiveness, an action that could well have backfired, see 37 C.F.R. 1.135(b) (an incomplete reply leads to abandonment of the application); MPEP § 711.”
Annotations are extracted automatically from the opinions in the
Syfert caselaw corpus and ranked by authority, recency, and
treatment. Dots show Syfertize treatment of the citing case itself.